Skip to Content
Top

BY Ron GIlmore

In cancer, cell signaling pathways are the critical chain of events that can either quash or quicken disease progression.

A multi-institutional international study led by scientists at The University of Texas MD Anderson Cancer Center has revealed new information about how molecules called long non-coding RNAs (lncRNA) interact with HIF-1, a signaling pathway that is overexpressed in many cancers. HIF-1 has been shown to regulate...

BY Laura Sussman

The 140,000 U.S. women diagnosed each year with early-stage breast cancer, when the tumor is still small and hasn’t spread, have a variety...

BY Karen Lu, M.D. and Mark Ebell, M.D.

The majority of women diagnosed with ovarian cancer face a difficult journey of repeated treatments that include aggressive surgeries and...

BY Scott Merville

Researchers at MD Anderson have found that pancreatic cancer tumors essentially spill their molecular secrets when they shed their complete DNA and RNA — wrapped inside protective lipid particles — into the bloodstream. This makes the tumors ripe for analysis with a liquid biopsy, according to a recent online report in the Annals of Oncology.

The scientists conducted whole genome, whole exome and gene expression analysis of tumors...

BY Clayton Boldt, Ph.D.

Breast cancer patients who delay chemotherapy more than 90 days after surgery are one-third more likely to die within five years, compared...

BY Clayton Boldt, Ph.D.

Depression significantly impacts five-year survival and recurrence in head and neck cancer patients, according to a new MD Anderson study....

BY Ron Gilmore

Immune suppressor cells called MDSCs (myeloid-derived suppressor cells) may be important in developing treatments for advanced prostate cancer...

BY Ron GIlmore

High amounts of dietary sugar increased the risk that mice would develop breast cancer, and that it would spread to their lungs, MD Anderson...